SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-20-035288
Filing Date
2020-11-05
Accepted
2020-11-05 16:14:35
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea129322-s3_tffpharma.htm S-3 258806
2 FORM OF SENIOR INDENTURE ea129322ex4-2_tffpharma.htm EX-4.2 339024
3 FORM OF SUBORDINATED INDENTURE ea129322ex4-3_tffpharma.htm EX-4.3 364413
4 FORM OF SENIOR NOTE ea129322ex4-4_tffpharma.htm EX-4.4 52433
5 FORM OF SUBORDINATED NOTE ea129322ex4-5_tffpharma.htm EX-4.5 47491
6 OPINION AND CONSENT OF GREENBERG TRAURIG, LLP ea129322ex5-1_tffpharma.htm EX-5.1 17164
7 CONSENT OF MARCUM LLP ea129322ex23-1_tffpharma.htm EX-23.1 2243
  Complete submission text file 0001213900-20-035288.txt   1082523
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-249870 | Film No.: 201290617
SIC: 2834 Pharmaceutical Preparations